Long-Term Survival of a Patient with Invasive Signet-Ring Cell Carcinoma of the Urinary Bladder Managed by Combined S-1 and Cisplatin Adjuvant Chemotherapy

Primary signet-ring cell carcinoma of the urinary bladder is extremely rare and patient survival is very poor. The disease usually presents at advanced stages because the cancer progresses rapidly. The only option for effective treatment is radical cystectomy, and no effective chemotherapy has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamakawa, Takashi, Kojima, Yoshiyuki, Naiki, Taku, Kubota, Yasue, Yasui, Takahiro, Tozawa, Keiichi, Hayashi, Yutaro, Kohri, Kenjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664482/
https://www.ncbi.nlm.nih.gov/pubmed/23738191
http://dx.doi.org/10.1155/2013/915874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664482/
https://www.ncbi.nlm.nih.gov/pubmed/23738191
http://dx.doi.org/10.1155/2013/915874

Ejemplares similares